ClinVar Miner

Submissions for variant NM_000179.2(MSH6):c.728G>A (p.Arg243His) (rs370157832)

Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 5
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
GeneDx RCV000160655 SCV000211261 uncertain significance not provided 2018-12-11 criteria provided, single submitter clinical testing This variant is denoted MSH6 c.728G>A at the cDNA level, p.Arg243His (R243H) at the protein level, and results in the change of an Arginine to a Histidine (CGC>CAC). This variant has been reported in an individual with ovarian cancer and at least one individual with advanced cancer (Lu 2015, Mandelker 2017). MSH6 Arg243His was not observed at a significant allele frequency in large population cohorts (Lek 2016). This variant is located within the nuclear localization signals (Gassman 2011). In silico analysis, which includes protein predictors and evolutionary conservation, supports that this variant does not alter protein structure/function. Based on currently available evidence, it is unclear whether MSH6 Arg243His is a pathogenic or benign variant. We consider it to be a variant of uncertain significance.
Invitae RCV000459365 SCV000551257 uncertain significance Hereditary nonpolyposis colorectal neoplasms 2019-12-31 criteria provided, single submitter clinical testing This sequence change replaces arginine with histidine at codon 243 of the MSH6 protein (p.Arg243His). The arginine residue is weakly conserved and there is a small physicochemical difference between arginine and histidine. This variant is present in population databases (rs370157832, ExAC 0.01%). This variant has been reported in an individual affected with ovarian cancer (PMID: 26689913). ClinVar contains an entry for this variant (Variation ID: 182611). General algorithms developed to predict the effect of missense changes on protein structure and function do not agree on the potential impact of this missense change (SIFT: "Tolerated"; PolyPhen-2: "Possibly Damaging"; Align-GVGD: "Class C0"). An algorithm developed specifically for the MSH6 gene predicts that this missense change is likely to be tolerated (PMID: 23621914). These predictions have not been confirmed by published functional studies. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.
Ambry Genetics RCV000568587 SCV000662495 uncertain significance Hereditary cancer-predisposing syndrome 2018-12-26 criteria provided, single submitter clinical testing Insufficient evidence
Color RCV000568587 SCV000685517 uncertain significance Hereditary cancer-predisposing syndrome 2020-03-03 criteria provided, single submitter clinical testing
Cancer Genomics Group,Japanese Foundation For Cancer Research RCV001030489 SCV001193643 uncertain significance Hereditary breast and ovarian cancer syndrome 2019-05-01 criteria provided, single submitter research

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.